ArticleBMC ophthalmology2025
Pearl-type posterior capsule opacification as a possible predisposing factor for malignant glaucoma: a case report.
Article in BMC ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Late-onset malignant glaucoma associated with Soemmering's ring: A case report.The Journal of international medical research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMalignant glaucoma (MG) is associated with a narrow angle or pseudoexfoliation (PEX)-induced laxity of the zonule. We describe a patient with massive posterior capsule opacification (PCO), i.e. Elschnig's Pearls (EP) and Soemmering's ring (SR) causing aqueous misdirection syndrome. CASE PRESENTATION: A 78-year-old female was referred with rapidly progressive left ocular pain, redness, blurred vision of 20/100, and intraocular pressure (IOP) of 60 mmHg. She had undergone cataract surgery 5 years prior without complications, with a preoperative diagnosis of moderate capsular PEX syndrome. She was first treated by intravenous 250 mg acetazolamide along with maximal pressure-lowering drops, 1% pilocarpine and a patent laser iridotomy. Despite adding 500 cc of 10% mannitol, IOP remained high for 3 days. A shallow anterior chamber with angle closure, myopic shift and filling of the posterior chamber by massive PCO led us to conclude an aqueous misdirection syndrome. We promptly switched 1% pilocarpine to 1% atropine and performed a laser iridotomy enlargement with a posterior capsulotomy and anterior hyaloidotomy. This rapidly controlled the condition with posterior displacement of the intraocular lens (IOL) and fading of the high-IOP associated symptoms.
conclusionsIdentifying malignant glaucoma could be challenging in the absence of immediate surgical circumstances. To our knowledge, this is the second description of PCO associated with MG. In this case, PCO was thought to narrow the iridocorneal angle and to cause a relative pupillary blockage, subsequently triggering aqueous humor misdirection to the vitreous and forward displacement of the iris-IOL diaphragm in the context of moderate PEX-induced zonular laxity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.